Bridgefront Capital »

Apellis Pharmaceuticals shares owned by Bridgefront Capital

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $636k 29k 21.87
2023-09-30 $259k 6.8k 38.04
2023-06-30 $239k 2.6k 91.10
2021-06-30 $214k 3.4k 63.13
2021-03-31 $201k 4.7k 42.96